Johnathan Violin

Affiliations: 
Duke University, Durham, NC 
Google:
"Johnathan Violin"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wobblish M, Carr R, Cowan C, et al. (2017) (224) Assessment of Nociceptive Sensitization with TRV9101, a Novel μ Receptor G Protein Pathway Selective Modulator (μ-GPS), versus Fentanyl, Morphine, and Oxycodone The Journal of Pain. 18: S32
Siuda ER, Carr R, Rominger DH, et al. (2016) Biased mu-opioid receptor ligands: a promising new generation of pain therapeutics. Current Opinion in Pharmacology. 32: 77-84
Tarigopula M, Davis RT, Mungai PT, et al. (2015) Cardiac myosin light chain phosphorylation and inotropic effects of a biased ligand, TRV120023, in a dilated cardiomyopathy model. Cardiovascular Research. 107: 226-34
Felker GM, Butler J, Collins SP, et al. (2015) Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure). Jacc. Heart Failure. 3: 193-201
Violin JD, Crombie AL, Soergel DG, et al. (2014) Biased ligands at G-protein-coupled receptors: Promise and progress Trends in Pharmacological Sciences. 35: 308-316
Rominger DH, Cowan CL, Gowen-MacDonald W, et al. (2014) Biased ligands: pathway validation for novel GPCR therapeutics. Current Opinion in Pharmacology. 16: 108-15
Strachan RT, Sun JP, Rominger DH, et al. (2014) Divergent transducer-specific molecular efficacies generate biased agonism at a G protein-coupled receptor (GPCR). The Journal of Biological Chemistry. 289: 14211-24
Violin JD, Crombie AL, Soergel DG, et al. (2014) Biased ligands at G protein-coupled receptors: promise and progress. [Trends in Pharmacological Sciences 35 (2014) 308-316] (DOI:10.1016/j.tips.2014.04.007) Trends in Pharmacological Sciences
Chen XT, Pitis P, Liu G, et al. (2013) Structure-activity relationships and discovery of a G protein biased μ opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain. Journal of Medicinal Chemistry. 56: 8019-31
Violin JD, Soergel DG, Boerrigter G, et al. (2013) GPCR biased ligands as novel heart failure therapeutics. Trends in Cardiovascular Medicine. 23: 242-9
See more...